Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

Published

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759 restricted stock units (RSUs) of the company’s common stock to 14 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of

Full Article